MedAware News

[Boston, MA 7/15/24] - MedAware (www.medaware.com), a leading developer of AI-based medication safety solutions, proudly announces that Dr. James Stevenson, PharmD, FASHP, has joined the company as a Strategic Advisor. Dr. Stevenson, Emeritus Professor of Pharmacy at the University of Michigan College of Pharmacy, brings a wealth of experience and expertise to his new role at MedAware. Prior to joining MedAware, Dr. Stevenson served as the VP and Chief Clinical Officer for Omnicell, Inc., where he spearheaded the company’s vision of Autonomous Pharmacy. His extensive leadership experience includes roles as Director of Pharmacy/Chief Pharmacy Officer at West Virginia University Hospitals, the Detroit Medical Center, and the University of Michigan Health System. Commenting on the potential for MedAware to transform current pharmacy practices, Dr. Stevenson noted, "Health system pharmacists today rely on processes that leverage disjointed and fragmented technology. There’s increasing pressure on pharmacists’ time and an exponential growth in information, which means the need for tools that enable safe, clinician-assisted decision-making will only grow. I choose to work with innovative disruptors, like MedAware, to continue elevating the practice of pharmacy by using data to direct pharmacists’ attention to situations where there is the greatest need. When we’re successful at incorporating novel technologies into our existing pharmacy workflows, pharmacists can do more, more safely— ultimately improving outcomes, safety, efficiency and reducing cost." Dr. Stevenson's perspective and thought leadership has been well recognized by his peers over the years. He received the Pharmacist of the Year award from the Michigan Pharmacists Association, the ASHP Award for Distinguished Leadership in Health System Pharmacy Practice, and the John W. Webb Lecture Award. He has also served on the ASHP Board of Directors and held officer positions in the Hospital Pharmacy Section of the International Pharmaceutical Federation (FIP). MedAware's patented AI driven software enables real-time evaluation of prescribed drugs against specific patient clinical conditions enhancing outcomes and patient safety. By incorporating a patient specific view of medication risk, the platform dramatically reduces the “alert burden” which frustrates pharmacists today. In addition, the platform continues to provide accurate and timely clinical insights beyond the point of dispensing, ensuring the patients remain safe while they take their medications. David Franklin, CEO of MedAware, expressed excitement at Dr. Stevenson becoming a MedAware Strategic Advisor, emphasizing the value of collaboration between industry and clinical thought leaders to drive innovation in healthcare. “We’re very fortunate to have Dr. Stevenson as a supporter and thought leader for our customers. Our collaboration is great example of how clinician-guided AI and ML can help health systems and care teams realize more from their investments in their EHR and other toolsets with the addition of a complimentary safety layer that does the heavy lifting for them. Partnering with experts like Dr. Stevenson demonstrates the value of collaboration between industry and clinical thought leaders to maintain ethical innovation with tools like clinically-conscious AI.” By harnessing Dr. Stevenson’s insights and MedAware's cutting-edge AI technology, the collaboration aims to drive continuous improvement in patient safety and medication management practices across healthcare organizations.

About MedAware:

MedAware’s medication safety monitoring platform lives within existing technology systems, EHRs, and devices to identify dangerous medication-related risks throughout the entire patient journey. By applying a personalized look at the appropriateness of a patient’s medication therapy at each stage of their treatment journey, MedAware’s technology can alert care teams to potential harm sooner than traditional tools—streamlining existing workflows, saving clinical time, and enabling intervention before harm occurs. For media inquiries or further information, please contact: Diane Smith Chief Commercial Officer, MedAware Email: [email protected]

Ballad Health partners with MedAware to leverage artificial intelligence platform to improve patient safety and optimize pharmacy workflows

MedAware, a medication safety monitoring technology, today announced a partnership with athenahealth, Inc. through the company’s Marketplace program. As part of the athenahealth® Marketplace, this newly integrated application is now available to athenahealth’s growing network of healthcare providers to help identify potential adverse drug events, analyze a patient’s risk of opioid dependency, alert providers to dangerous drug interactions, and more. “We know what we’re doing is valuable, as we’re seeing more than a 40% behavior change rate,” said Gidi Stein, MD, Ph.D., Co-Founder and CEO of MedAware. “At MedAware, we provide continuous monitoring during the prescribing event and throughout a patient’s entire course of treatment. When MedAware triggers an indication of risk, a corresponding action is taken by the prescriber or care team.” MedAware applies AI-based technology to healthcare data systems that function similar to outlier detection technology used to identify potential credit card fraud. By leveraging near-real-time EHR and lab data, MedAware can continuously monitor a patient’s personal risk of medication-related adverse events and notify the care team of patients in need of intervention. Dr. Stein adds, “What we provide goes beyond traditional medication alert systems and drug-drug interaction knowledge bases. Because no two patients or providers are alike, we apply a level of specificity and scrutiny that takes into account the appropriateness of a medication for an individual patient and an individual prescriber.” athenahealth is a network-enabled, results-oriented software and services company that offers medical records, revenue cycle, patient engagement, and care coordination services for ambulatory and hospital clients nationwide. The company’s vision is to build a thriving ecosystem that delivers accessible, high-quality, and sustainable healthcare for all. As a Marketplace partner, MedAware joins a community of innovative, like-minded healthcare professionals who are looking to bring best-in-class solutions to the athenahealth provider base. To learn more about MedAware’s newly integrated application, please visit MedAware’s product listing page on the Marketplace. Additionally, MedAware will be hosting a webinar on August 25 to demo its solution for the athenahealth EHR. Registration can be found here. About MedAware MedAware's medication safety monitoring platform lives within existing technology systems, EHRs, and devices to identify dangerous medication-related risks throughout the entire patient journey. Built using longitudinal and real-time patient data, advanced machine learning algorithms identify medication errors, opioid dependency risk, evolving adverse drug events, and more. Due to the high clinical relevancy of its medication alerts, providers have been shown to change their prescribing behavior significantly more often than with traditional systems alone. Founded in 2012, MedAware has offices in the United States and Israel. About athenahealth Marketplaces The athenahealth Marketplace, the largest EHR app store, is where athenahealth customers find innovative healthcare IT solutions that extend athenahealth services and allow customers to create highly tailored user experiences. Customers use Marketplace partner solutions to boost practice efficiency, increase patient satisfaction, and engage patients in their own care. The Marketplace has more than 250 solutions across 60 categories that are seamlessly integrated with athenaOne, athenahealth’s network-enabled platform through which the company offers medical records, revenue cycle, patient engagement, and care coordination service offerings.